NDA 022503 describes METAXALONE, which is a drug marketed by
Actavis Labs Fl Inc,
Amneal Pharms,
Appco,
Ingenus Pharms Llc,
Lannett Co Inc,
Mountain,
Primus Pharms,
Sandoz, and
Sciegen Pharms Inc, and is included in nine NDAs. It is available from
thirty-three suppliers. Additional details are available on the
METAXALONE profile page.
The generic ingredient in METAXALONE is
metaxalone. There are twenty
drug master file entries for this compound. Thirty-three
suppliers are listed for this compound. Additional details are available on the
metaxalone profile page.